Drug intelligence / Profile preview

hispolon

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Hispolon is a naturally occurring phenolic pigment and polyphenol primarily isolated from the medicinal mushroom species *Phellinus linteus*. It has been extensively investigated for its diverse pharmacological properties, including potent antioxidant, anti-inflammatory, and antineoplastic activities. Mechanistically, hispolon exerts its anticancer effects by inducing apoptosis through the modulation of reactive oxygen species (ROS) levels, activation of Caspase-3, and inhibition of the NF-kappa B signaling pathway. It also demonstrates anti-metastatic potential by suppressing the expression of Matrix metalloproteinase-2 (MMP-2) and Matrix metalloproteinase-9 (MMP-9). Despite its therapeutic promise in treating various cancers such as melanoma, breast cancer, and lung cancer, hispolon's clinical translation is limited by its poor aqueous solubility and low bioavailability. Consequently, current research focuses on developing advanced delivery systems, including cyclodextrin inclusion complexes and liposomal formulations, to enhance its pharmacokinetic profile and chemotherapeutic efficiency.

Other names
6-(3,4-dihydroxyphenyl)-4-hydroxyhexa-3,5-dien-2-one
02

Targets

CASP3 (Caspase-3)CASP8 (Caspase-8)CASP9 (Caspase-9)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)NF-κB

Beyond the preview

Go deeper on hispolon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hispolon.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call